News
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...
GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...
The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
18h
Zacks.com on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic Nineties and beach-body-ready Noughties, the judgement is real. It is ...
KATIE Price has revealed her son Harvey now weighs 30st, as she gave fans an update on him taking weight loss jabs. The ...
21h
TAG24 on MSNWeight loss jabs linked to lower dementia and stroke riskWeight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
New weight management drugs could be used to create a global metabolic health revolution and improve longevity, if investment ...
The Canadian Press on MSN19h
BC limits sales of two more diabetes drugs amid off-label use for weight lossBritish Columbia's Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
14hon MSNOpinion
In today's digital age, brands are facing increasing pressure to be transparent. Recent incidents, like the Air India crash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results